Overview
Makoto Ito practices practicing medicine in Nishi, Japan.
Mr. Ito is highly rated in 1 condition, according to our data. His clinical expertise encompasses Galactosialidosis, Cryptococcosis, and Mucopolysaccharidoses (MPS).
He is actively involved in clinical research, co-authoring 46 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Makoto Ito
Is Makoto Ito a top-rated expert for Galactosialidosis?
MediFind is an objective health platform that identifies experts based on real-world data. Makoto Ito is classified as an Advanced expert for Galactosialidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Makoto Ito participate in research or clinical trials?
Yes. Makoto Ito has published 46 articles and abstracts on conditions like Galactosialidosis. You can view a list of Makoto Ito's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- GalactosialidosisMr. Ito isAdvanced. Learn about Galactosialidosis.
- Experienced
- CryptococcosisMr. Ito isExperienced. Learn about Cryptococcosis.
- Mucopolysaccharidoses (MPS)Mr. Ito isExperienced. Learn about Mucopolysaccharidoses (MPS).